C2I is home to over 25 biotechnology startups with the capability to provide more than 50 life science entrepreneurs a place to call home. Our residents have created over 100 highly skilled jobs and C2I had helped make an economic impact of 450M+ in funds raised in the Commonwealth.
SynerK, Inc. is a biotechnology company engaged in the development of life changing treatment in the areas of cancer, inflammatory and rare diseases. SynerK utilizes antisense technology to specifically silence genes that are responsible for various diseases.
CreaGen Inc. is a premier chemistry-based drug discovery service company that provides cost-effective, high quality discovery research services to biotech and pharmaceutical companies.
Rubix Strategies is a technical business think tank firm that delivers innovative solutions [From Research & Development to initial Product Life-Cycle launch] to industries of the technical discipline.
Javelin Biotech provides an integrative preclinical drug testing platform for pharmaceutical and biotech industries by merging organ-on-chip (OoC) technologies and computational biology/AI to optimize lead selection and clinical trial design. Human OoC technologies culture human tissues in microphysiological environments enabling the most human relevant in vitro drug tests. The preclinical safety, efficacy, and pharmacokinetics data are translated to predictions of how drugs perform in humans.
Kebotix harnesses the power of its breakthrough platform that combines artificial intelligence and robotic automation to discover chemicals and materials significantly faster and more affordably.
Fluidic Analytics envisions a world where information about proteins and their behaviour transforms our understanding of how the biological world operates, and helps all of us make better decisions about how we diagnose diseases, develop treatments and maintain our personal well-being.
New Objective have been industry leaders in high-sensitivity LC-MS research through innovative life-science sample prep and delivery tools. Founded in 1997 on PicoTip® technology, New Objective has remained on the cutting edge of nanobore chromatography and nanospray-based mass spectrometry through engaging, ongoing communication with our customers, continuous innovation, and unwavering commitment to quality.
Dynamic Biosensors is a provider of instruments, consumables, and services in the field of analytical systems for the characterization of biomolecules and molecular interactions. Dynamic Biosensors commercializes switchSENSE® technology, a groundbreaking platform technology for the analysis of biomolecules with applications in R&D and drug development.